T. C. Pearson

878 total citations
19 papers, 497 citations indexed

About

T. C. Pearson is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, T. C. Pearson has authored 19 papers receiving a total of 497 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Genetics, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Oncology. Recurrent topics in T. C. Pearson's work include Hemoglobinopathies and Related Disorders (6 papers), Blood properties and coagulation (3 papers) and Immune Response and Inflammation (3 papers). T. C. Pearson is often cited by papers focused on Hemoglobinopathies and Related Disorders (6 papers), Blood properties and coagulation (3 papers) and Immune Response and Inflammation (3 papers). T. C. Pearson collaborates with scholars based in United Kingdom, United States and Israel. T. C. Pearson's co-authors include Allan D. Kirk, C P Larsen, Andrew Adams, Stuart J. Knechtle, Christian P. Larsen, N. G. P. Slater, Diane Z. Alexander, Bogumila T. Konieczny, M. Messinezy and R P Lowry and has published in prestigious journals such as The Journal of Immunology, American Journal of Transplantation and Journal of Clinical Pathology.

In The Last Decade

T. C. Pearson

17 papers receiving 486 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
T. C. Pearson United Kingdom	10	205	159	129	84	62	19	497
Lechler Ri United Kingdom	11	259 1.3×	75 0.5×	92 0.7×	32 0.4×	29 0.5×	30	579
Cornelis A. Verburgh Netherlands	10	106 0.5×	79 0.5×	89 0.7×	146 1.7×	17 0.3×	21	619
F Bouissou France	12	318 1.6×	95 0.6×	124 1.0×	67 0.8×	154 2.5×	36	781
Wendy Whitley United States	6	131 0.6×	254 1.6×	264 2.0×	18 0.2×	22 0.4×	8	486
Michelle Long Schoettler United States	9	171 0.8×	106 0.7×	47 0.4×	40 0.5×	161 2.6×	39	366
Mustimbo Roberts United States	13	197 1.0×	201 1.3×	171 1.3×	7 0.1×	40 0.6×	23	592
Fumihiko Inoue Japan	13	87 0.4×	23 0.1×	297 2.3×	16 0.2×	75 1.2×	30	544
Mathieu Vautier France	13	58 0.3×	22 0.1×	102 0.8×	75 0.9×	33 0.5×	30	596
Kyung Nam Koh South Korea	15	87 0.4×	13 0.1×	90 0.7×	79 0.9×	202 3.3×	29	411
P Mahendra United Kingdom	10	103 0.5×	19 0.1×	34 0.3×	71 0.8×	338 5.5×	32	505

Countries citing papers authored by T. C. Pearson

Since Specialization

Citations

This map shows the geographic impact of T. C. Pearson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. C. Pearson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. C. Pearson more than expected).

Fields of papers citing papers by T. C. Pearson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. C. Pearson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. C. Pearson. The network helps show where T. C. Pearson may publish in the future.

Co-authorship network of co-authors of T. C. Pearson

This figure shows the co-authorship network connecting the top 25 collaborators of T. C. Pearson. A scholar is included among the top collaborators of T. C. Pearson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. C. Pearson. T. C. Pearson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Kirk, Allan D., A. Guasch, Huanhuan Xu, et al.. (2014). Renal Transplantation Using Belatacept Without Maintenance Steroids or Calcineurin Inhibitors. American Journal of Transplantation. 14(5). 1142–1151. 104 indexed citations

Pearson, T. C., et al.. (2008). Chlorambucil-induced myelofibrosis. Clinical & Laboratory Haematology. 6(3). 293–297.

Larsen, C P, Stuart J. Knechtle, Andrew Adams, T. C. Pearson, & Allan D. Kirk. (2006). A New Look at Blockade of T-cell Costimulation: A Therapeutic Strategy for Long-term Maintenance Immunosuppression. American Journal of Transplantation. 6(5). 876–883. 109 indexed citations

Pakarian, F, Susan Bewley, & T. C. Pearson. (2001). Prenatal hypoxic ischaemic-encephalopathy leading to microcephaly in a sickle cell pregnancy with recovery from a ‘terminal CTG’. British Journal of Obstetrics and Gynaecology. 108(2). 218–221. 1 indexed citations

Pearson, T. C. & M. Messinezy. (2000). Classification and diagnostic criteria of the erythrocytoses. Reply. Clinical & Laboratory Haematology. 22(2). 129–130. 2 indexed citations

Messinezy, M. & T. C. Pearson. (1999). REVIEWThe classification and diagnostic criteria of the erythrocytoses (polycythaemias). Clinical & Laboratory Haematology. 21(5). 309–316. 22 indexed citations

Walker, Matthew C., et al.. (1999). Sickle cell disease and nitrous oxide-induced neuropathy. Clinical & Laboratory Haematology. 21(6). 409–412. 47 indexed citations

Pearson, T. C.. (1998). Floppy pinnae in Siamese cats.. PubMed. 143(16). 456–456. 1 indexed citations

Lakkis, Fadi G., Bogumila T. Konieczny, Sohail Saleem, et al.. (1997). Blocking the CD28-B7 T cell costimulation pathway induces long term cardiac allograft acceptance in the absence of IL-4. The Journal of Immunology. 158(5). 2443–2448. 102 indexed citations

10.

Konieczny, Bogumila T., et al.. (1995). Interleukin-10 eliminates anti-CD3 monoclonal antibody-induced mortality and prolongs heart allograft survival in inbred mice.. PubMed. 27(1). 392–4. 17 indexed citations

11.

Majumdar, Gautam, J. Phillips, & T. C. Pearson. (1994). Short Communication: Prolonged Severe Neutropenia after Chlorambucil Therapy and Prompt Reversal with GM-CSF. Leukemia & lymphoma. 15(3-4). 361–362.

12.

Pearson, T. C., Andrew Bushell, Christopher Darby, et al.. (1993). Lymphocyte changes associated with prolongation of cardiac allograft survival in adult mice using anti-CD4 monoclonal antibody. Clinical & Experimental Immunology. 92(2). 211–217. 13 indexed citations

13.

Phillips, J., Paul Bass, Gautam Majumdar, et al.. (1993). Renal failure caused by leukaemic infiltration in chronic lymphocytic leukaemia.. Journal of Clinical Pathology. 46(12). 1131–1133. 32 indexed citations

14.

Taylor, Judith, Jay Acharya, T. C. Pearson, & R. P. H. Thompson. (1991). Zinc improves the filterability of sickle erythrocytes at intermediate oxygen partial pressures. Clinical Science. 81(3). 433–438. 6 indexed citations

15.

Pearson, T. C., Joren C. Madsen, P. J. Morris, & Kathryn J. Wood. (1990). The induction of transplantation tolerance using donor antigen and CD4 monoclonal antibody.. PubMed. 22(4). 1955–6. 5 indexed citations

16.

Eridani, S, N. G. P. Slater, Amarendra K. Singh, & T. C. Pearson. (1985). Intravenous and oral demethoxydaunorubicin (NSC 256?439) in the treatment of acute leukemia and lymphoma: A pilot study. Annals of Hematology. 50(6). 369–372. 14 indexed citations

17.

SHAW, MARCIA, et al.. (1985). Epidermolysis bullosa acquisita associated with chronic lymphatic leukaemia. Clinical and Experimental Dermatology. 10(2). 162–168. 10 indexed citations

18.

Eridani, S, T. C. Pearson, N. G. P. Slater, & Amarendra K. Singh. (1984). A Pilot Study of Epidoxorubicin (NSC 256942) in Combination Treatment of Acute Leukaemia and Non-Hodgkin’s Lymphoma. Oncology. 41(6). 383–386. 4 indexed citations

19.

Pearson, T. C., et al.. (1982). Exchange Transfusion in Life-Threatening Sickling Crises. Journal of the Royal Society of Medicine. 75(10). 777–780. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact